Name: UMIN ID:
Unique ID issued by UMIN | UMIN000018619 |
---|---|
Receipt number | R000021546 |
Scientific Title | Research on markers for omalizumab therapy in asthma |
Date of disclosure of the study information | 2015/08/11 |
Last modified on | 2022/06/01 15:57:20 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/08/10 11:48:59 | ||
2 | Update | 2015/08/11 14:42:27 | Other related information Other related information |
|
3 | Update | 2016/09/06 10:50:11 | Date trial data considered complete |
|
4 | Update | 2016/09/06 10:51:09 | Recruitment status |
|
5 | Update | 2022/06/01 15:45:42 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address TEL Last name of contact person Last name of contact person Organization Organization Zip code Address TEL Name of primary person or sponsor Organization Address3 Tel3 Email3 Organization Organization Address Address Tel |
|
6 | Update | 2022/06/01 15:47:02 | Publication of results Number of participants that the trial has enrolled |
|
7 | Update | 2022/06/01 15:49:07 | Date of IRB Last follow-up date |
|
8 | Update | 2022/06/01 15:57:20 | URL releasing protocol URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |